Europe Allergy Immunotherapies Market to Grow at a CAGR of XXXX% to reach US$ XXXX Million from 2020 to 2027

Europe Allergy Immunotherapies Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Treatment (Subcutaneous Immunotherapy (SCIT) and Sublingual Immunotherapy (SLIT)); Allergy Type (Allergic Rhinitis, Asthma, Food Allergy, Venom Allergy and Others); Distribution Channel (Hospital Pharmacy, Retail Pharmacy and Online Pharmacy), and Country

Publication Month: Sep 2020 | Report Code: TIPRE00014180 | No. of Pages: 123 | Category: Pharmaceuticals | Status: Published
Covid

The Europe allergy immunotherapies market was valued at US$ 544.14 million in 2019 and is projected to reach US$ 1,228.14 million by 2027; it is expected to grow at a CAGR of 10.8% during the forecast period.

The allergy immunotherapies market is expected to grow owing to key driving factors such as the increasing prevalence of allergic disorders and technological advancements in sublingual dosage formulations.

Allergen immunotherapy is a medical treatment useful for environmental allergies, allergies to insect bites, and asthma. Allergic disorders are the most common problems examined by primary care physicians and pediatricians, according to the International Study of Asthma and Allergies in Childhood (ISAAC), around 20% of children in the European area suffer from hay fever. The Europe Allergy Immunotherapy Market is anticipated to observe a phase of consistent growth, owing to various factors affecting the healthcare sector such as focus of government expenditure towards healthcare sector primarily in research and development accompanied by structural changes introduced into the system to enable several healthcare providers to concentrate in ensuring sufficient volume is handled. Additionally, high awareness and an increasing need for advanced treatments will further pose lucrative business growth opportunities in the foreseeable future.

The Covid-19 pandemic has harmed allergy immunotherapies market size, with small and medium scale companies struggling to sustain their businesses in the near-term future. Industry leaders are now focusing on creating new business practices to deal with crises like covid-19 pandemic.

Europe Allergy Immunotherapies Market Revenue and Forecast to 2027 (US$ Mn)

Get more information on this report :

 

EUROPE ALLERGY IMMUNOTHERAPIES MARKET SEGMENTATION

Europe Allergy Immunotherapies Market – By Treatment

  • Subcutaneous Immunotherapy (SCIT)
  • Sublingual Immunotherapy (SLIT)

Europe Allergy Immunotherapies Market – By Allergy Type

  • Allergic Rhinitis
  • Asthma
  • Food Allergy
  • Venom Allergy
  • Others

Europe Allergy Immunotherapies Market – By Distribution Channel

  • Hospital Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Europe Allergy Immunotherapies Market – By Country

  • UK
  • Germany
  • France
  • Italy
  • Spain

Company Profiles

  • HAL Allergy B.V.
  • ALK Abello A/S 
  • Stallergenes Greer
  • Anergis
  • Circassia 

TABLE OF CONTENTS

1.          Introduction

1.1         Scope of the Study

1.2         The Insight Partners Research Report Guidance

1.3         Market Segmentation

1.3.1          Europe Allergy Immunotherapies Market – By Treatment

1.3.2          Europe Allergy Immunotherapies Market – By Allergy Type

1.3.3          Europe Allergy Immunotherapies Market – By Distribution Channel

1.3.4          Europe Allergy Immunotherapies Market – By Geography

2.          Europe Allergy Immunotherapies Market – Key Takeaways

3.          Research Methodology

3.1         Coverage

3.2         Secondary Research

3.3         Primary Research

4.          Europe Allergy Immunotherapies Market – Market Landscape

4.1         Overview

4.2         PEST Analysis

4.2.1          Europe PEST Analysis

4.3         Expert Opinion

5.          Europe Allergy immunotherapies Market – Key Market Dynamics

5.1         Key Market Drivers

5.1.1          Growing Prevalence of Allergic Disorders

5.1.2          Technological Advancements in Sublingual Dosage Formulations

5.2         Key Market Restraint

5.2.1          Drawbacks Associated with the Use of Allergy Immunotherapy

5.2.2          Regulatory Variations Across Region

5.2.3          Restricted Healthcare Expenditure

5.3         Key Market Opportunities

5.3.1          Technological and Research Breakthrough in Healthcare System

5.4         Future Trends

5.4.1          Increasing SLIT Segment in Allergy Immunotherapy

5.5         Impact Analysis

6.          Allergy immunotherapies market – Europe Analysis

6.1.1          Europe: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

7.          Europe Allergy Immunotherapies Market Analysis– by Treatment

7.1         Overview

7.2         Europe Allergy Immunotherapies Market Share, By Treatment, 2019 & 2027 (%)

7.3         Subcutaneous Immunotherapy (SCIT)

7.3.1          Overview

7.4         Sublingual Immunotherapy (SLIT)

7.4.1          Overview

8.          Europe Allergy Immunotherapies Market Analysis– by Allergy Type

8.1         Overview

8.2         Allergy Immunotherapies Market Share, By Allergy Type, 2019 & 2027 (%)

8.3         Allergic Rhinitis

8.3.1          Overview

8.3.2          Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)

8.4         Asthma

8.4.1          Overview

8.4.2          Asthma Market Revenue and Forecasts to 2027 (US$ Million)

8.5         Food Allergy

8.5.1          Overview

8.5.2          Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)

8.6         Venom Allergy

8.6.1          Overview

8.6.2          Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)

8.7         Other Allergies

8.7.1          Overview

8.7.2          Others Market Revenue and Forecasts to 2027 (US$ Million)

9.          Europe Allergy Immunotherapies Market Analysis– by Distribution Channel

9.1         Overview

9.2         Allergy Immunotherapies Market Share, By Distribution Channel, 2019 & 2027 (%)

9.3         Hospital Pharmacy

9.3.1          Overview

9.3.2          Europe Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

9.4         Retail Pharmacy

9.4.1          Overview

9.4.2          Retail PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)

9.5         Online Pharmacy

9.5.1          Overview

9.5.2          Europe Online PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)

10.       Allergy Immunotherapies Market Analysis And Forecasts To 2027 – Geographical Analysis

10.1.1       Overview

10.1.2       Europe: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.3       Europe: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.4       Europe: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.5       Europe: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.6       Europe: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)

10.1.7       Germany: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.1          Germany: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.7.2          Germany: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.7.3          Germany: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.7.4          Germany: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.8       France: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.1          France: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.8.2          France: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.8.3          France: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.8.4          France: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.9       UK: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.1          UK: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.9.2          UK: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.9.3          UK: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.9.4          UK: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.10     Italy: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.1       Italy: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.10.2       Italy: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.10.3       Italy: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.10.4       Italy: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

10.1.11     Spain: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.1       Spain: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

10.1.11.2       Spain: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

10.1.11.3       Spain: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

10.1.11.4       Spain: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.       Impact of COVID-19 Pandemic on Europe Allergy Immunotherapies Market

12.       Company Profiles

12.1       ALK-Abelló A/S

12.1.1       Key Facts

12.1.2       Business Description

12.1.3       Products and Services

12.1.4       Financial Overview

12.1.5       SWOT Analysis

12.1.6       Key Developments

12.2       LETIPharma

12.2.1       Key Facts

12.2.2       Business Description

12.2.3       Products and Services

12.2.4       Financial Overview

12.2.5       SWOT Analysis

12.2.6       Key Developments

12.3       Stallergenes Greer

12.3.1       Key Facts

12.3.2       Business Description

12.3.3       Products and Services

12.3.4       Financial Overview

12.3.5       SWOT Analysis

12.3.6       Key Developments

12.4       HAL Allergy B.V.

12.4.1       Key Facts

12.4.2       Business Description

12.4.3       Products and Services

12.4.4       Financial Overview

12.4.5       SWOT Analysis

12.4.6       Key Developments

12.5       Johnson and Johnson Services, Inc.

12.5.1       Key Facts

12.5.2       Business Description

12.5.3       Products and Services

12.5.4       Financial Overview

12.5.5       SWOT Analysis

12.5.6       Key Developments

12.6       Anergis

12.6.1       Key Facts

12.6.2       Business Description

12.6.3       Products and Services

12.6.4       Financial Overview

12.6.5       SWOT Analysis

12.6.6       Key Developments

12.7       DBV Technologies

12.7.1       Key Facts

12.7.2       Business Description

12.7.3       Products and Services

12.7.4       Financial Overview

12.7.5       SWOT Analysis

12.7.6       Key Developments

12.8       Dermapharm Holding

12.8.1       Key Facts

12.8.2       Business Description

12.8.3       Products and Services

12.8.4       Financial Overview

12.8.5       SWOT Analysis

12.8.6       Key Developments

12.9       Allergy Therapeutics

12.9.1       Key Facts

12.9.2       Business Description

12.9.3       Products and Services

12.9.4       Financial Overview

12.9.5       SWOT Analysis

12.9.6       Key Developments

13.       Appendix

13.1       Glossary of Terms

 


LIST OF TABLES

Table 1.             Europe: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 2.             Europe: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 3.             Europe: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 4.             Germany: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 5.             Germany: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 6.             Germany: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 7.             France: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 8.             France: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 9.             France: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 10.           UK: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 11.           UK: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 12.           UK: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.           Italy: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 14.           Italy: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 15.           Italy: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 16.           Spain: Allergy Immunotherapies Market, by Treatment – Revenue and Forecast to 2027 (USD Million)

Table 17.           Spain: Allergy Immunotherapies Market, by Allergy Type – Revenue and Forecast to 2027 (USD Million)

Table 18.           Spain: Allergy Immunotherapies Market, Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 19.           Glossary of Terms, Allergy Immunotherapies Market

 


LIST OF FIGURES

Figure 1.            Europe Allergy Immunotherapies Market Segmentation

Figure 2.            Global Allergy Immunotherapies Market Overview

Figure 3.            Subcutaneous Immunotherapy (SCIT) Segment Held Largest Share of Allergy immunotherapies market

Figure 4.            Europe Allergy Immunotherapies Market- Leading Country Markets (US$ Million)

Figure 5.            Europe PEST Analysis

Figure 6.            Europe Allergy immunotherapies Market Impact Analysis of Driver and Restraints

Figure 7.            Europe: Allergy Immunotherapies Market Revenue and Forecast to 2027 (USD Million)

Figure 8.            Europe Allergy Immunotherapies Market Share, by Treatment, 2019 & 2027 (%)

Figure 9.            Europe Subcutaneous Immunotherapy (SCIT) Market Revenue and Forecasts to 2027 (US$ Million)

Figure 10.          Europe Sublingual Immunotherapy (SLIT) Market Revenue and Forecasts to 2027 (US$ Million)

Figure 11.          Allergy Immunotherapies Market Share, by Allergy Type, 2019 & 2027 (%)

Figure 12.          Allergic Rhinitis Market Revenue and Forecasts to 2027 (US$ Million)

Figure 13.          Asthma Market Revenue and Forecasts to 2027 (US$ Million)

Figure 14.          Food Allergy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 15.          Venom Allergy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 16.          Others Market Revenue and Forecasts to 2027 (US$ Million)

Figure 17.          Allergy Immunotherapies Market Share, by Distribution Channel, 2019 & 2027 (%)

Figure 18.          Europe Hospital Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 19.          Retail PharmacyMarket Revenue and Forecasts to 2027 (US$ Million)

Figure 20.          Europe Online Pharmacy Market Revenue and Forecasts to 2027 (US$ Million)

Figure 21.          Europe: Allergy Immunotherapies Market, by Key Country – Revenue (2019) (USD Million)

Figure 22.          Europe: Allergy Immunotherapies Market Revenue and Forecast to 2027 (USD Million)

Figure 23.          Europe: Allergy Immunotherapies Market, by Country, 2019 & 2027 (%)

Figure 24.          Germany: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 25.          France: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 26.          UK: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 27.          Italy: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 28.          Spain: Allergy Immunotherapies Market – Revenue and Forecast to 2027 (USD Million)

Figure 29.          Impact of COVID-19 Pandemic on allergy immunotherapies market in European Countries

 

The List of Companies - Europe Allergy Immunotherapies Market

  1. HAL Allergy B.V.
  2. ALK Abello A/S 
  3. Stallergenes Greer
  4. Anergis
  5. Circassia 
  • Determine prospective investment areas based on a detailed trend analysis of the Europe allergy immunotherapy market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different allergy immunotherapy segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the allergy immunotherapy market, providing a clear picture of future opportunities that will help Analyse, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the Europe immunotherapy market.
TIPRE00014180
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing